PARTNERING FOR NEW OPPORTUNITIES

Partnering with other companies is of strategic importance to Abera. Our proprietary technologies enable the discovery, development, and production of vaccines and therapeutic proteins. We are interested in partnering with companies to further develop our vaccine development pipeline.  Whether it is a strategic alliance, licensing, or marketing agreement, Abera wishes to work closely with its partners to ensure mutual success. 

Team up? Contact me


Anders Ericson
CEO
anders.ericson@aberabio.com